<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04430257</url>
  </required_header>
  <id_info>
    <org_study_id>H-40454</org_study_id>
    <nct_id>NCT04430257</nct_id>
  </id_info>
  <brief_title>Pre-exposure Prophylaxis (PrEP) for Health</brief_title>
  <acronym>PrEP</acronym>
  <official_title>Copy of Efficacy of a Community-based PrEP Uptake Intervention for People Who Inject Drugs in the US Northeast</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial will test the efficacy of &quot;PrEP for Health,&quot; a behavioral
      intervention to improve the use of antiretroviral pre-exposure prophylaxis (PrEP) among
      at-risk people who inject drugs (PWID) in two syringe service program (SSP) settings in
      Lawrence and Boston/Cambridge, Massachusetts. The investigators will equally randomize 200
      PWID to receive either (a) the &quot;PrEP for Health&quot; intervention condition involving
      theory-informed HIV and PrEP education, motivational interviewing, problem-solving and
      planning, and ongoing patient navigation (n=100), or (b) the standard of care condition
      involving PrEP information and referrals (n=100). Successful PrEP uptake (via
      medical/pharmacy records), adherence (via drug levels in hair), and persistence (via medical/
      pharmacy records) over 12 months will be evaluated. The degree to which intervention efficacy
      occurs through specific conceptual mediators (e.g., PrEP knowledge, motivation,
      self-efficacy) and differs according to hypothesized moderators (e.g., age, gender, sexual
      risk) will be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PrEP uptake</measure>
    <time_frame>12 months</time_frame>
    <description>PrEP uptake will be assessed via medical/pharmacy records for prescription refill maintenance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PrEP adherence</measure>
    <time_frame>12 months</time_frame>
    <description>PrEP adherence will be assessed by drug levels in hair samples.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PrEP persistence</measure>
    <time_frame>12 months</time_frame>
    <description>PrEP persistence will be assessed using medical records to confirm provider follow-up visits.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Substance Dependence</condition>
  <condition>HIV (Human Immunodeficiency Virus)</condition>
  <arm_group>
    <arm_group_label>PrEP for health</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the PreEP (pre-exposure prophylaxis) for health arm will receive theory informed HIV and PrEP education, motivational interviewing, problem-solving and planning, and ongoing patient navigation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the standard of care arm will receive PrEP information and referrals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>HIV and PrEP education</intervention_name>
    <description>Navigators will deliver Social Cognitive Theory-informed HIV and PrEP education.</description>
    <arm_group_label>PrEP for health</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational interviewing</intervention_name>
    <description>Bachelors-level PrEP Navigators who are trained in motivational interviewing (MI) will use MI to promote the behavioral intervention.</description>
    <arm_group_label>PrEP for health</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Problem-solving and planning</intervention_name>
    <description>Bachelors-level PrEP Navigators will assist participants with problem-solving and planning.</description>
    <arm_group_label>PrEP for health</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient navigation</intervention_name>
    <description>Ongoing PrEP navigation support to promote participants' initial and continued engagement with PrEP clinics affiliated with the two study sites</description>
    <arm_group_label>PrEP for health</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PrEP information</intervention_name>
    <description>A brief video that describes what PrEP is and how it works to prevent HIV via sexual and injection transmission will be shown to participants.</description>
    <arm_group_label>PrEP for health</arm_group_label>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Referrals</intervention_name>
    <description>Study staff will provide basic information about PrEP and referrals to PrEP clinicians.</description>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-uninfected (by rapid test)

          -  Reporting past-month injection of any drugs

          -  One or more HIV risk behaviors (past-month receptive syringe sharing, transactional
             sex, or condomless sex with an HIV-infected or unknown-status partner)

          -  Not currently on post-exposure preparation (PEP) or pre-exposure preparation (PrEP)

          -  Never taken PrEP

          -  Able to understand and speak English

        Exclusion Criteria:

          -  Unable to provide informed consent due to severe mental or physical illness, cognitive
             impairment, or substance intoxication at the time of enrollment

          -  Living in Massachusetts (MA) for &lt;3 months

          -  Planning to move out of MA within a year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela Bazzi, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>BU School of Public Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angela Bazzi, PhD, MPH</last_name>
    <phone>617-414-1355</phone>
    <email>abazzi@bu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eugene S Massey, BA</last_name>
    <phone>617-358-3220</phone>
    <email>massey@bu.edu</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 10, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>June 10, 2020</last_update_submitted>
  <last_update_submitted_qc>June 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PrEP (pre-exposure prophylaxis )</keyword>
  <keyword>PWID (people who inject drugs)</keyword>
  <keyword>SSP (syringe service program)</keyword>
  <keyword>HIV education</keyword>
  <keyword>Motivational interviewing</keyword>
  <keyword>Self efficacy</keyword>
  <keyword>Social cognitive theory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

